Henderson Michael Thomas's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Jan 16, 2026
- Accession no.
- 0001104659-26-004659
- Filed
- Jan 16, 2026
- Trade date
- Jan 14, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.62M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson Michael ThomasCIK 0001779990 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | Common Stock | SSaleDisposed | −1,440 | $78.64 | −$113,241.6 | 1,211,547 | Direct | |
| Jan 14, 2026 | Common Stock | SSaleDisposed | −8,476 | $79.82 | −$676,554.32 | 1,203,071 | Direct | |
| Jan 14, 2026 | Common Stock | SSaleDisposed | −2,374 | $81.00 | −$192,294 | 1,200,697 | Direct | |
| Jan 14, 2026 | Common Stock | SSaleDisposed | −1,854 | $82.41 | −$152,788.14 | 1,198,843 | Direct | |
| Jan 14, 2026 | Common Stock | SSaleDisposed | −5,386 | $83.16 | −$447,899.76 | 1,193,457 | Direct | |
| Jan 14, 2026 | Common Stock | SSaleDisposed | −470 | $83.79 | −$39,381.3 | 1,192,987 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.